UCB teams up with UK-based charity for epilepsy research

Coinciding with International Epilepsy Day, UK-based charity The Epilepsy Society and Belgium’s UCB (Euronext: UCB) have announced a new collaboration to advance understanding of epilepsy.

Using whole genome sequencing, the project will focus on researching genetic components of the condition, treatment responses and the impact on patient experiences.

UCB’s UK-based unit will work collaboratively with The Epilepsy Society over the next five years to “develop an improved and deeper understanding of the complex nature of epilepsy, leveraging the recent technological advances in the field, such as genome sequencing, machine learning approaches and analysis of genetic biomarkers.”

The long-term goal of the collaboration is to create new insights to design and develop improved, personalized approaches to the management of epilepsy.